- Home
- XRTX vs GHSI Comparison
XRTX vs GHSI Comparison
Compare XRTX & GHSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- GHSI
- Stock Information
- Founded
- XRTX 2011
- GHSI 2009
- Country
- XRTX Canada
- GHSI United States
- Employees
- XRTX N/A
- GHSI N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- GHSI Biotechnology: Pharmaceutical Preparations
- Sector
- XRTX Health Care
- GHSI Health Care
- Exchange
- XRTX Nasdaq
- GHSI Nasdaq
- Market Cap
- XRTX 5.0M
- GHSI 4.2M
- IPO Year
- XRTX N/A
- GHSI 2019
- Fundamental
- Price
- XRTX $1.82
- GHSI $3.26
- Analyst Decision
- XRTX Strong Buy
- GHSI Hold
- Analyst Count
- XRTX 1
- GHSI 1
- Target Price
- XRTX $14.00
- GHSI N/A
- AVG Volume (30 Days)
- XRTX 125.9K
- GHSI 112.1K
- Earning Date
- XRTX 11-14-2024
- GHSI 11-11-2024
- Dividend Yield
- XRTX N/A
- GHSI N/A
- EPS Growth
- XRTX N/A
- GHSI N/A
- EPS
- XRTX N/A
- GHSI 4.99
- Revenue
- XRTX N/A
- GHSI $12,228,713.00
- Revenue This Year
- XRTX N/A
- GHSI $12.01
- Revenue Next Year
- XRTX N/A
- GHSI $10.00
- P/E Ratio
- XRTX N/A
- GHSI $0.69
- Revenue Growth
- XRTX N/A
- GHSI 119.79
- 52 Week Low
- XRTX $1.09
- GHSI $3.04
- 52 Week High
- XRTX $67.72
- GHSI $18.00
- Technical
- Relative Strength Index (RSI)
- XRTX 53.06
- GHSI 25.07
- Support Level
- XRTX $1.52
- GHSI $3.17
- Resistance Level
- XRTX $2.51
- GHSI $3.34
- Average True Range (ATR)
- XRTX 0.28
- GHSI 0.19
- MACD
- XRTX 0.04
- GHSI 0.06
- Stochastic Oscillator
- XRTX 31.00
- GHSI 7.29
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About GHSI Guardion Health Sciences Inc.
Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s.